The global sterilization services market size accounted for USD 5.60 billion in 2024, grew to USD 5.98 billion in 2025 and is projected to surpass around USD 10.64 billion by 2034, representing a healthy CAGR of 6.62% between 2024 and 2034. The North America sterilization services market size is calculated at USD 2.18 billion in 2024 and is expected to grow at a fastest CAGR of 6.73% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Sterilization Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Sterilization Services Market, by Method, 2024-2034
8.1.1. Gas Modalities
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Radiation Modalities
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Dry Heat Sterilization
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Other Methods
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Sterilization Services Market, by Business Type, 2024-2034
9.1.1. Contract Sterilization Services
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Sterilization Validation Services
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Sterilization Services Market, by Mode of Delivery, 2024-2034
10.1.1. On-Site
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Off-Site
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Sterilization Services Market, by End-Use, 2024-2034
11.1.1. Healthcare Facilities
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Medical Device Companies
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Pharmaceutical And Biotech Companies
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Other End-Users
11.1.4.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.1.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.2.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.3.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.4.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Business Type (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Mode of Delivery (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
13.1. Steris Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Stryker Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. 3m Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Ecolab Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sterigenics International LLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Cretex Companies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Noxilizer Inc
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Beta-Gamma-Service Gmbh & Co. Kg
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cosmed Group Inc.,
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medline Industries Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample